Step 1 topics → Respiratory → PFT Patterns — Obstructive vs Restrictive

PFT Patterns — Obstructive vs Restrictive

USMLE Step 1 trap: Incorrectly expects a decreased FEV1/FVC ratio in restrictive lung disease. In restrictive disease, FEV1/FVC ratio is normal or increased (>0.70) because FVC falls proportionally more than FEV1; a decreased ratio defines obstruction.

PFT patterns are one of the highest-yield topics on USMLE Step 1, and they show up in both direct recall questions and longer clinical vignettes where you're handed a table of numbers and asked to identify the pattern or the disease. The core concept is straightforward: obstruction means impaired airflow (low FEV1/FVC ratio), restriction means reduced lung volumes (low TLC), and the FEV1/FVC ratio is what separates them. But the exam pushes past that — it expects you to interpret DLCO values, know what bronchodilator reversibility means quantitatively, and map specific diseases to specific PFT patterns including the distinction between intrinsic and extrinsic restrictive disease.

The tricky part is that students often treat obstructive and restrictive as parallel in structure, leading to wrong assumptions. The biggest trap: thinking the FEV1/FVC ratio must be low in restrictive disease 'because both values are reduced.' That reasoning fails because restriction compresses the FVC more than FEV1, keeping the ratio normal or elevated. Similarly, students assume DLCO must be low in all obstructive diseases — but asthma spares alveolar architecture, so DLCO is preserved (or even elevated). Emphysema is the outlier in the obstructive category where DLCO falls, and that distinction is explicitly tested on USMLE Step 1.

Another common gap is knowing when to use methacholine versus bronchodilator testing — these serve opposite diagnostic purposes and the exam loves to flip them. On top of that, extrinsic restrictive diseases (think obesity, kyphoscoliosis, neuromuscular disease) are frequently glossed over in study materials, but USMLE Step 1 tests whether you know that their DLCO is normal because the lung parenchyma is intact. Getting these nuances right separates a 'good enough' understanding from a reliable one.

From real student decks
97%have cards covering this topic
89%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: The FEV1/FVC ratio is decreased in restrictive lung disease because both FEV1 and FVC are reduced.
Right: In restrictive disease, FEV1/FVC ratio is normal or increased (>0.70) because FVC falls proportionally more than FEV1; a decreased ratio defines obstruction.
In restrictive disease, both FEV1 and FVC fall — but FVC falls more because the lung cannot fully expand, shrinking the total available volume. FEV1 is the volume exhaled in one second, and in a stiff but unobstructed lung, you can still empty a high proportion of that smaller volume quickly. The result is an FEV1/FVC ratio that is normal (≥0.70) or even supranormal. A low FEV1/FVC ratio is the definition of obstruction, not restriction — never assign it to a restrictive pattern.
Common mistake
Wrong: DLCO is normal in emphysema because airflow obstruction is the primary defect.
Right: DLCO is decreased in emphysema due to destruction of alveolar walls, which reduces the surface area available for gas diffusion.
DLCO measures the lung's ability to transfer gas across the alveolar-capillary membrane, which depends on surface area. Emphysema destroys alveolar walls — this is the pathological hallmark — and that destruction directly reduces the available diffusion surface. Airflow obstruction is the functional consequence, but alveolar loss is the structural reality, so DLCO falls. A low DLCO in the context of obstruction should immediately point you toward emphysema rather than asthma or chronic bronchitis.
Common mistake
Wrong: DLCO is decreased in asthma because it is an obstructive disease like emphysema.
Right: DLCO is normal (or even elevated) in asthma because alveolar architecture is preserved; decreased DLCO distinguishes emphysema from asthma among obstructive diseases.
Asthma causes bronchoconstriction and airway inflammation, but the alveoli themselves are structurally normal. Because the diffusion surface is intact, DLCO is preserved — and during acute hyperinflation it can appear elevated due to increased alveolar capillary recruitment. This is a high-value distinguishing feature: if a vignette describes an obstructive pattern with normal or elevated DLCO, think asthma or chronic bronchitis. Decreased DLCO in an obstructive pattern = emphysema. Don't apply emphysema's physiology to all obstructive diseases.
Common mistake
Wrong: Methacholine challenge is used to confirm asthma when spirometry is already abnormal.
Right: Methacholine challenge is used when baseline spirometry is normal but asthma is suspected; a ≥20% fall in FEV1 (PC20) is a positive test indicating bronchial hyperreactivity.
Methacholine is a bronchoconstrictor used as a provocation test — its entire purpose is to unmask bronchial hyperreactivity when baseline spirometry looks normal. If spirometry is already abnormal and showing obstruction, you don't need methacholine; you use bronchodilator testing to check for reversibility instead. The USMLE Step 1 scenario for methacholine is a patient with episodic symptoms (e.g., exercise-induced cough, suspected asthma) but a normal FEV1/FVC at rest. A ≥20% fall in FEV1 at the provocative concentration (PC20) confirms the diagnosis.
Common mistake
Gap: Unaware that extrinsic restrictive diseases have normal DLCO because alveolar tissue is unaffected
Extrinsic restrictive diseases (obesity, kyphoscoliosis, neuromuscular disease) show decreased TLC and FVC with normal DLCO because the lung parenchyma itself is intact.
In extrinsic restrictive disease — obesity, kyphoscoliosis, neuromuscular weakness — the lung parenchyma is completely normal. The restriction comes from an outside mechanical constraint on lung expansion, not from intrinsic lung pathology. Because the alveoli and capillaries are intact, DLCO is normal. This contrasts with intrinsic restrictive disease (e.g., IPF, sarcoidosis) where parenchymal scarring or infiltration directly impairs diffusion, causing DLCO to fall. Normal DLCO + reduced TLC/FVC = extrinsic restriction; low DLCO + reduced TLC/FVC = intrinsic restriction.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Interpret FEV1, FVC, and FEV1/FVC ratio values to diagnose an obstructive vs restrictive pattern — including why a normal or elevated FEV1/FVC ratio does not rule out severe disease in restriction.
  2. Predict DLCO in specific conditions: decreased in emphysema and pulmonary fibrosis, normal-to-elevated in asthma, normal in extrinsic restrictive diseases, and elevated in pulmonary hemorrhage or polycythemia.
  3. Identify when bronchodilator reversibility testing applies (≥12% and 200 mL increase in FEV1 confirms reversible obstruction like asthma) versus when methacholine challenge applies (used when baseline spirometry is normal but asthma is suspected; positive if FEV1 drops ≥20%).
  4. Categorize diseases as obstructive, intrinsic restrictive, or extrinsic restrictive — and apply the correct expected PFT pattern, including TLC and DLCO, to each category.

Can you avoid these mistakes?

A 55-year-old smoker has FEV1/FVC of 0.58, reduced FEV1, and a DLCO that is 45% of predicted. A 45-year-old lifelong nonsmoker with episodic wheezing has FEV1/FVC of 0.61, reduced FEV1, and DLCO that is 95% of predicted. What single PFT value most reliably distinguishes these two diagnoses, and what does it tell you?
A patient with severe obesity undergoes PFTs showing reduced TLC, reduced FVC, FEV1/FVC ratio of 0.82, and DLCO of 92% predicted. What is the pattern, and why is the DLCO normal despite the restrictive physiology?
A 28-year-old with seasonal cough and dyspnea has completely normal spirometry at rest. You suspect asthma. What test do you order next, what result confirms the diagnosis, and why would bronchodilator testing not be appropriate here?
In a table of PFT values, you see: FVC decreased, FEV1 decreased, FEV1/FVC ratio increased to 0.88, TLC decreased, DLCO decreased. What is the pattern, and what category of disease does the low DLCO suggest — extrinsic or intrinsic restrictive? Name two diseases that fit.

Related topics

Lung Volumes and Capacities Lung Development Stages Surfactant Production and Neonatal RDS Bronchopulmonary Dysplasia Congenital Diaphragmatic Hernia

See how your Anki deck covers this topic.

Upload your deck for a free audit →